AIG
CTMX icon

American International Group’s CytomX Therapeutics CTMX Stock Holding History

American International Group’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,200
Closed -$86K – 3128
2022
Q1 		$86K Sell
32,200
-2,267
-7% -$8.71K ﹤0.01% 2646
2021
Q4 		$149K Sell
34,467
-1,031
-3% -$6.04K ﹤0.01% 2533
2021
Q3 		$181K Sell
35,498
-844
-2% -$4.52K ﹤0.01% 2486
2021
Q2 		$230 Buy
36,342
+443
+1% +$3.45K ﹤0.01% 2417
2021
Q1 		$277 Buy
35,899
+9,655
+37% +$76.4K ﹤0.01% 2189
2020
Q4 		$172 Sell
26,244
-752
-3% -$5.37K ﹤0.01% 2360
2020
Q3 		$180K Sell
26,996
-615
-2% -$4.56K ﹤0.01% 2196
2020
Q2 		$230K Buy
27,611
+957
+4% +$8.89K ﹤0.01% 2046
2020
Q1 		$204K Sell
26,654
-1,541
-5% -$10.7K ﹤0.01% 1890
2019
Q4 		$234K Sell
28,195
-238
-0.8% -$1.61K ﹤0.01% 2122
2019
Q3 		$210K Sell
28,433
-198
-0.7% -$1.95K ﹤0.01% 2135
2019
Q2 		$321K Buy
28,631
+248
+0.9% +$2.6K ﹤0.01% 1956
2019
Q1 		$305K Sell
28,383
-920
-3% -$13.6K ﹤0.01% 1979
2018
Q4 		$442K Sell
29,303
-226
-0.8% -$3.35K ﹤0.01% 1748
2018
Q3 		$546K Buy
29,529
+4,407
+18% +$100K ﹤0.01% 1839
2018
Q2 		$574K Buy
25,122
+6,551
+35% +$167K ﹤0.01% 1739
2018
Q1 		$528K Sell
18,571
-998
-5% -$28.5K ﹤0.01% 1683
2017
Q4 		$413K Buy
19,569
+92
+0.5% +$1.91K ﹤0.01% 1898
2017
Q3 		$354K Buy
19,477
+1,456
+8% +$22.7K ﹤0.01% 1960
2017
Q2 		$279K Buy
18,021
+5,441
+43% +$82K ﹤0.01% 2078
2017
Q1 		$217K Buy
12,580
+834
+7% +$11K ﹤0.01% 2131
2016
Q4 		$129K Sell
11,746
-31
-0.3% -$376 ﹤0.01% 2451
2016
Q3 		$185K Buy
11,777
+18
+0.2% +$218 ﹤0.01% 2224
2016
Q2 		$120K Buy
11,759
+7,333
+166% +$83.6K ﹤0.01% 2474
2016
Q1 		$57K Buy
+4,426
New +$61.5K ﹤0.01% 3802

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's CTMX Position: Q2 2022 in Review

American International Group sold out of CytomX Therapeutics (CTMX) in Q2 2022, closing a stake of 32,200 shares — an estimated $86K sold.

American International Group first reported a position in CTMX in Q1 2016 and held it in 25 quarters. The position peaked at $574K in Q2 2018. 98 funds tracked by Wall St. Rank hold CTMX as of Q2 2022.

  • American International Group reported no remaining CytomX Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 32,200 CytomX Therapeutics shares in Q2 2022, an estimated $86K.
  • American International Group first reported a position in CytomX Therapeutics in Q1 2016 and held it in 25 quarters.
  • American International Group's CytomX Therapeutics position peaked at $574K in Q2 2018.
  • 98 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.